Tripos Completes Purchase of Optive Research for $7.9M | GenomeWeb

NEW YORK, Jan. 5 (GenomeWeb News) - Tripos has completed the acquisition of Optive Research, a discovery informatics software developer, for roughly $7.9 million in stock and cash, the St. Louis-based company said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.